{"id":"https://openalex.org/W7225309591","doi":"https://doi.org/10.1136/jitc-2026-017100","title":"Steering the immune response: cancer vaccines and the next era of cancer immunotherapy","display_name":"Steering the immune response: cancer vaccines and the next era of cancer immunotherapy","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225309591","doi":"https://doi.org/10.1136/jitc-2026-017100","pmid":"https://pubmed.ncbi.nlm.nih.gov/42988573"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-017100","doi":"https://doi.org/10.1136/jitc-2026-017100","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-017100","pdf_url":"https://jitc.bmj.com/content/14/11/e017100.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/11/e017100.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026029856","display_name":"Lisa Helene Butterfield","orcid":"https://orcid.org/0000-0002-3439-9844","observed_orcids":["https://orcid.org/0000-0002-3439-9844"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa H Butterfield","raw_affiliation_strings":["Immunotherapy Consultant, San Francisco, California, USA"],"raw_orcid":"https://orcid.org/0000-0002-3439-9844","affiliations":[{"raw_affiliation_string":"Immunotherapy Consultant, San Francisco, California, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070669850","display_name":"James L. Gulley","orcid":"https://orcid.org/0000-0002-6569-2912","observed_orcids":["https://orcid.org/0000-0002-6569-2912"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James L Gulley","raw_affiliation_strings":["NCI, National Institutes of Health, Bethesda, Maryland, USA"],"raw_orcid":"https://orcid.org/0000-0002-6569-2912","affiliations":[{"raw_affiliation_string":"NCI, National Institutes of Health, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"11","first_page":"e017100","last_page":"e017100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7279999852180481,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7279999852180481,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.2712000012397766,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.8069999814033508},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9629999995231628},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8410000205039978},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9710000157356262},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.843999981880188},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8180000185966492},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.6079999804496765},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.656000018119812},{"id":"https://openalex.org/keywords/vaccine-delivery","display_name":"vaccine delivery","score":0.335999995470047}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.810699999332428},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6977999806404114},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6851000189781189},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6736999750137329},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6606000065803528},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6495000123977661},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5853000283241272},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.5715000033378601},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.513700008392334},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4799000024795532},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4632999897003174},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.46140000224113464},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4530999958515167},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.3716000020503998},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3619000017642975},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.3375000059604645},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.3224000036716461},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.3188000023365021},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.3093999922275543},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3059000074863434},{"id":"https://openalex.org/C2776624504","wikidata":"https://www.wikidata.org/wiki/Q7907955","display_name":"Vaccine therapy","level":4,"score":0.29679998755455017},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.2955999970436096},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2939999997615814},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.2840000092983246},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.2759999930858612},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.26739999651908875},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.2603999972343445},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2581999897956848},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.2565999925136566},{"id":"https://openalex.org/C2780234812","wikidata":"https://www.wikidata.org/wiki/Q1787013","display_name":"Cancer prevention","level":3,"score":0.25189998745918274}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-017100","doi":"https://doi.org/10.1136/jitc-2026-017100","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-017100","pdf_url":"https://jitc.bmj.com/content/14/11/e017100.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmid:42988573","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42988573","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-017100","doi":"https://doi.org/10.1136/jitc-2026-017100","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-017100","pdf_url":"https://jitc.bmj.com/content/14/11/e017100.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225309591.pdf","grobid_xml":"https://content.openalex.org/works/W7225309591.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W4323652587","https://openalex.org/W4379645081","https://openalex.org/W4392230251","https://openalex.org/W4407768113","https://openalex.org/W4417177189","https://openalex.org/W7141134743","https://openalex.org/W7170758706"],"related_works":["https://openalex.org/W3041363051","https://openalex.org/W7213107664","https://openalex.org/W2886083944","https://openalex.org/W7213971841","https://openalex.org/W7128777558","https://openalex.org/W7131320504","https://openalex.org/W7216387582","https://openalex.org/W4390048110","https://openalex.org/W1116139823","https://openalex.org/W2790921164"],"abstract_inverted_index":{"The":[0,93,124],"recent":[1],"announcements":[2],"that":[3,50,178],"personalized":[4],"mRNA":[5],"cancer":[6,33,42,61,148],"vaccines":[7,62],"(1)":[8],"when":[9,22,115,121],"combined":[10],"with":[11,17,31,130,154],"pembrolizumab":[12],"improved":[13],"outcomes":[14],"in":[15,41,113,128],"patients":[16,30],"high-risk":[18,29],"melanoma":[19],"and":[20,91,108,160],"(2)":[21],"given":[23],"as":[24,98],"a":[25,164,173],"single":[26],"agent":[27],"to":[28,67,144],"colorectal":[32],"failed":[34],"may":[35,87],"represent":[36],"an":[37,141,185],"important":[38],"inflection":[39],"point":[40,171],"immunotherapy.":[43],"While":[44],"immune":[45,70,187,194],"checkpoint":[46,85],"inhibitors":[47],"have":[48],"demonstrated":[49],"antitumor":[51],"immunity":[52],"can":[53,77],"be":[54,103],"unleashed":[55],"by":[56],"removing":[57],"inhibitory":[58],"signals,":[59],"therapeutic":[60,99,147],"offer":[63],"the":[64,69,73,131,134,155,182,193],"complementary":[65],"opportunity":[66],"steer":[68],"response":[71,188],"toward":[72,172],"tumor.":[74],"Personalized":[75],"vaccination":[76,100],"direct":[78],"T":[79],"cells":[80],"against":[81],"tumor-specific":[82],"neoantigens,":[83],"while":[84],"blockade":[86],"sustain":[88],"their":[89],"function":[90],"activity.":[92],"implications":[94],"extend":[95],"beyond":[96],"melanoma,":[97],"could":[101],"potentially":[102],"applied":[104],"across":[105],"tumor":[106,116],"types":[107],"clinical":[109,161],"settings,":[110],"particularly":[111],"earlier":[112],"disease":[114],"burden":[117],"is":[118,139],"low\u2014but":[119],"only":[120,180],"optimally":[122],"delivered.":[123],"National":[125,135],"Cancer":[126],"Institute,":[127],"collaboration":[129],"Foundation":[132],"for":[133],"Institutes":[136],"of":[137,157,176],"Health,":[138],"developing":[140],"international":[142],"initiative":[143],"evaluate":[145],"diverse":[146],"vaccine":[149],"strategies,":[150],"including":[151],"mRNA-based":[152],"approaches,":[153],"goal":[156],"accelerating":[158],"discovery":[159],"translation":[162],"over":[163],"2\u20133-year":[165],"time":[166],"frame.":[167],"Together,":[168],"these":[169],"developments":[170],"next":[174],"generation":[175],"immunotherapy":[177],"not":[179],"releases":[181],"brakes":[183],"on":[184],"anticancer":[186],"but":[189],"increasingly":[190],"directs":[191],"where":[192],"system":[195],"attacks.":[196]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-06T00:00:00"}